Previous Article | Next Article ![]()
Antimicrobial Agents and Chemotherapy, March 2006, p. 1086-1088, Vol. 50, No. 3
0066-4804/06/$08.00+0 doi:10.1128/AAC.50.3.1086-1088.2006
Copyright © 2006, American Society for Microbiology. All Rights Reserved.
Markku Koskela,5
Erkki Eerola,6
Jaakko Uksila,7
Sini Pajarre,8 and
Hilpi Rautelin1*
Department of Bacteriology and Immunology, Haartman Institute, University of Helsinki and HUSLAB Helsinki University Central Hospital Laboratory, Helsinki,1 Department of Food and Environmental Hygiene, University of Helsinki, Helsinki,2 Department of Clinical Microbiology, University of Kuopio, Kuopio,3 Department of Clinical Microbiology, North Karelia Central Hospital, Joensuu,4 Department of Microbiology, University Central Hospital of Oulu, Oulu,5 Department of Medical Microbiology, University of Turku, Turku,6 Central Finland Central Hospital, Jyväskylä,7 Satakunta Central Hospital, Pori, Finland8
Received 18 October 2005/ Returned for modification 20 November 2005/ Accepted 23 November 2005
The in vitro susceptibilities of 478 Campylobacter jejuni and Campylobacter coli strains isolated from Finnish subjects during 2002 to 2004 were determined. Susceptibility to erythromycin remained high, and telithromycin did not offer any advantage over erythromycin. Reduced susceptibilities to fluoroquinolones and doxycycline were detected almost exclusively among isolates of foreign origin.
Present address: Department of Microbiology, Vaasa Central Hospital, Vaasa, Finland.
| Clin. Vaccine Immunol. | Clin. Microbiol. Rev. |
|---|---|
| J. Clin. Microbiol. | ALL ASM JOURNALS |